Regeneron Pharmaceuticals, Inc. (REGN) Oppenheimer 34th Annual Healthcare Life Sciences Conference (Transcript)

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Oppenheimer 34th Annual Healthcare Life Sciences Conference February 14, 2024 1:20 PM ET Company Participants Ryan Crowe - SVP, IR David Snow - SVP, Global Head of Dupixent franchise Conference Call Participants Hartaj Singh - Oppenheimer Hartaj Singh Great. Thank you, everybody, for joining us on the second day here of this track of the Oppenheimer Healthcare Conference of 2024. Got David Snow, the SVP and the Global Head of Dupixent franchise; and Ryan Crowe, ...